logging in or signing up ODDS rahulpupu Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 147 Category: Education License: All Rights Reserved Like it (0) Dislike it (0) Added: May 11, 2011 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... By: gdeepali172 (2 month(s) ago) sir i m student of m ph in aurangabad i also want this ppt.. can u send me on my mail ... thank you... Saving..... Post Reply Close Saving..... Edit Comment Close By: gdeepali172 (2 month(s) ago) sir Saving..... Post Reply Close Saving..... Edit Comment Close By: vishalbhosale (12 month(s) ago) sir, im vishal bhsoale studying m pharm at mip pune i wat your ppt for presentation purpose. plz guide me my email id vishalbhosale.49@rediffmail.com Saving..... Post Reply Close Saving..... Edit Comment Close By: vishalbhosale (12 month(s) ago) sir, im vishal bhsoale studying m pharm at mip pune i wat your ppt for presentation purpose. plz guide me my email id vishalbhosale.49@rediffmail.com Saving..... Post Reply Close Saving..... Edit Comment Close Premium member Presentation Transcript Ocular Drug Delivery System : Ocular Drug Delivery System Presented by : Mahesh W. Thube, M.Pharm II, Dept. Of P’ceu, GCP, Aurangabad .Human eye consist of :- : Human eye consist of :-Mechanism Of Ocular Absorption: Mechanism Of Ocular AbsorptionGeneral Pathway For Ocular Absorption: General Pathway For Ocular AbsorptionRole Of Polymer In ODDS. : Role Of Polymer In ODDS . Solution Viscosity : Solution Drainage. Polymer Mucoadhesive Vehicle: Retained in the eye due to non-covalent bonding between with conjuctival mucine. Mucine is capable of picking of 40-80 times of weight of water. Factors Affecting Intraocular Bioavailability: 1. Inflow & Outflow of Lacrimal fluids. 2. Efficient naso-lacrimal drainage. 3. Interaction of drug with proteins of Lacrimal fluid. 4. Dilution with tears.Classification Of Ophthalmic Dosage Form: : Classification Of Ophthalmic Dosage Form:Ocular indication of controlled-release systems: Ocular indication of controlled-release systems Indication Drug & Disease 1. Short, topical ocular half-life Heparin for Ligneous disease 2. Small, topical ocular, therapeutic index Pilocarpine for chronic open-angle Glaucoma 3. Systemic side effects Timolol for Glaucoma and cyclosporin A for graft rejection 4. Need for combination therapy Cromoglycate and corticosteroid for Asthma and Allergies 5. Drug delivery over a prolonged period Acute corneal infections, Corneal Graft rejection episodes 6. Long-continued low dosage for therapy or prophylaxis Prevention of Corneal Graft Rejection or Herpetic diseases,Ocular Control Release System: Ophthalmic Inserts : Ocular Control Release System: Ophthalmic Inserts Definition:- Solid or Semisolid in nature, - Placed in lower Fornix - Composed of Polymeric vehicle containing drug. Desired Criteria For Control Release Ocular Inserts.Types Of Ocular Control Release System: Types Of Ocular Control Release SystemA) Non-Erodible :: A) Non-Erodible : 1.Ocusert: Developed by Alza Corporation, Oval flexible ocular insert, Release Rate: 20-40mg/hr for 7day Consist of- Annular ring : Impregnated with Ti0 2 : For Visibility Part Material Drug Reservoir Pilocarpine Carrier material Alginic acid Rate controller Ethylene vinyl acetate copolymer Energy Source Conc. Of Pilocarpine Delivery Portal Copolymer membrane 2) Contact Lens :: 2) Contact Lens : Presoaked Hydrophilic lens. Drug Release : within 1 st 30 Min . Alternate approach : incorporate drug either as sol n or suspension of solid monomer mixture. Release rate is up to : 180 hr . 3) Diffusional Inserts : Central reservoir of drug enclosed in Semi permeable or micro porous membrane for diffusion of drug. Diffusion is controlled by Lacrimal Fluid penetrating through it. It prevents continues decrease in release rate due to barrier. Release follows : Zero Order Kinetics .B) Erodible Inserts: B) Erodible Inserts 1.Lacrisert: Sterile, Rod Shaped device. Composition: HPC without preservative. Weight:5mg, Dimension:Diameter:12.5mm, Length:3.5mm Use:-Dry eye treatment, Keratitis Sica . 2.SODI: Soluble Ocular Drug Insert. Small water soluble developed for Cosmonauts who could not use their eye drop in liquid condition. Composition : Acryl amide, Vinyl Pyrolidone, Ethylacrylate. Weight 15-16 mg. In 10-15 sec Softens; In 10-15 min. turns in Viscous Liquids; After 30-60min. Becomes Polymeric Solution.Advantages of SODI : : Advantages of SODI : Single SODI application :replaces 4-12 eye drops Instillation, or 3-6 application of Ointments. Once a day treatment of Glaucoma & Trachoma. 3)Minidisc: It is made up of counter disc with Convex front & Concave back surface in contact with eye ball. 4-5mm in diameter. Composition : Silicon based pre polymer. Hydrophilic or Hydrophobic. Drug release from 170 hr.C) Nanoparticle:: C) Nanoparticle:D) Liposome: D) LiposomeAdvances in ocular drug delivery: Advances in ocular drug delivery 1. Ophthalmic gel for pilocarpine Poloxamer 407 (low viscosity, optical clarity, mucomimetic property) 2. Ophthalmic prodrug Dipivalyl epinephrine ( Dipivefrin ) Lipophilic increase in corneal absorption Esterase within cornea and aqueous humor 3. Continuous delivery system based upon the osmotic property Thin flat layer, contoured three-dimensional unit Conform to the space of the upper cul-de-sac Delivery of diethyl carbamazine in ocular onchocerciasis4.Gel delivery system: 4.Gel delivery system Biodegradable polyisobutyl-cyano acrylate (PIBCA) colloidal particulate system of pilocarpine to incorporate it into a Pluronic F127 (PF 127)-based gel delivery system. 5)Mucoadhesive Polymer. mucoadhesive polymer, the tamarind seed polysaccharide, as a delivery system for the ocular administration of hydrophilic and hydrophobic antibiotics.Reference:: Reference: N.K.Jain, Advances in Controlled & Novel Drug Delivery, CBS Publication, & distributor, New Delhi, pg No.219-223. Remington & Gennaro ; The Science & Practice Of Pharmacy. Mack Publication Company. Easton, Pennsylvania. Pg. No. 1563-1567. Web Sites: www.vision-care-guide.com www.google/images/eye/anatomy& physiologyThank You....! : Thank You....! Creativity is allowing oneself to make mistakes. Art is knowing which one to keep. You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.
ODDS rahulpupu Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 147 Category: Education License: All Rights Reserved Like it (0) Dislike it (0) Added: May 11, 2011 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... By: gdeepali172 (2 month(s) ago) sir i m student of m ph in aurangabad i also want this ppt.. can u send me on my mail ... thank you... Saving..... Post Reply Close Saving..... Edit Comment Close By: gdeepali172 (2 month(s) ago) sir Saving..... Post Reply Close Saving..... Edit Comment Close By: vishalbhosale (12 month(s) ago) sir, im vishal bhsoale studying m pharm at mip pune i wat your ppt for presentation purpose. plz guide me my email id vishalbhosale.49@rediffmail.com Saving..... Post Reply Close Saving..... Edit Comment Close By: vishalbhosale (12 month(s) ago) sir, im vishal bhsoale studying m pharm at mip pune i wat your ppt for presentation purpose. plz guide me my email id vishalbhosale.49@rediffmail.com Saving..... Post Reply Close Saving..... Edit Comment Close Premium member Presentation Transcript Ocular Drug Delivery System : Ocular Drug Delivery System Presented by : Mahesh W. Thube, M.Pharm II, Dept. Of P’ceu, GCP, Aurangabad .Human eye consist of :- : Human eye consist of :-Mechanism Of Ocular Absorption: Mechanism Of Ocular AbsorptionGeneral Pathway For Ocular Absorption: General Pathway For Ocular AbsorptionRole Of Polymer In ODDS. : Role Of Polymer In ODDS . Solution Viscosity : Solution Drainage. Polymer Mucoadhesive Vehicle: Retained in the eye due to non-covalent bonding between with conjuctival mucine. Mucine is capable of picking of 40-80 times of weight of water. Factors Affecting Intraocular Bioavailability: 1. Inflow & Outflow of Lacrimal fluids. 2. Efficient naso-lacrimal drainage. 3. Interaction of drug with proteins of Lacrimal fluid. 4. Dilution with tears.Classification Of Ophthalmic Dosage Form: : Classification Of Ophthalmic Dosage Form:Ocular indication of controlled-release systems: Ocular indication of controlled-release systems Indication Drug & Disease 1. Short, topical ocular half-life Heparin for Ligneous disease 2. Small, topical ocular, therapeutic index Pilocarpine for chronic open-angle Glaucoma 3. Systemic side effects Timolol for Glaucoma and cyclosporin A for graft rejection 4. Need for combination therapy Cromoglycate and corticosteroid for Asthma and Allergies 5. Drug delivery over a prolonged period Acute corneal infections, Corneal Graft rejection episodes 6. Long-continued low dosage for therapy or prophylaxis Prevention of Corneal Graft Rejection or Herpetic diseases,Ocular Control Release System: Ophthalmic Inserts : Ocular Control Release System: Ophthalmic Inserts Definition:- Solid or Semisolid in nature, - Placed in lower Fornix - Composed of Polymeric vehicle containing drug. Desired Criteria For Control Release Ocular Inserts.Types Of Ocular Control Release System: Types Of Ocular Control Release SystemA) Non-Erodible :: A) Non-Erodible : 1.Ocusert: Developed by Alza Corporation, Oval flexible ocular insert, Release Rate: 20-40mg/hr for 7day Consist of- Annular ring : Impregnated with Ti0 2 : For Visibility Part Material Drug Reservoir Pilocarpine Carrier material Alginic acid Rate controller Ethylene vinyl acetate copolymer Energy Source Conc. Of Pilocarpine Delivery Portal Copolymer membrane 2) Contact Lens :: 2) Contact Lens : Presoaked Hydrophilic lens. Drug Release : within 1 st 30 Min . Alternate approach : incorporate drug either as sol n or suspension of solid monomer mixture. Release rate is up to : 180 hr . 3) Diffusional Inserts : Central reservoir of drug enclosed in Semi permeable or micro porous membrane for diffusion of drug. Diffusion is controlled by Lacrimal Fluid penetrating through it. It prevents continues decrease in release rate due to barrier. Release follows : Zero Order Kinetics .B) Erodible Inserts: B) Erodible Inserts 1.Lacrisert: Sterile, Rod Shaped device. Composition: HPC without preservative. Weight:5mg, Dimension:Diameter:12.5mm, Length:3.5mm Use:-Dry eye treatment, Keratitis Sica . 2.SODI: Soluble Ocular Drug Insert. Small water soluble developed for Cosmonauts who could not use their eye drop in liquid condition. Composition : Acryl amide, Vinyl Pyrolidone, Ethylacrylate. Weight 15-16 mg. In 10-15 sec Softens; In 10-15 min. turns in Viscous Liquids; After 30-60min. Becomes Polymeric Solution.Advantages of SODI : : Advantages of SODI : Single SODI application :replaces 4-12 eye drops Instillation, or 3-6 application of Ointments. Once a day treatment of Glaucoma & Trachoma. 3)Minidisc: It is made up of counter disc with Convex front & Concave back surface in contact with eye ball. 4-5mm in diameter. Composition : Silicon based pre polymer. Hydrophilic or Hydrophobic. Drug release from 170 hr.C) Nanoparticle:: C) Nanoparticle:D) Liposome: D) LiposomeAdvances in ocular drug delivery: Advances in ocular drug delivery 1. Ophthalmic gel for pilocarpine Poloxamer 407 (low viscosity, optical clarity, mucomimetic property) 2. Ophthalmic prodrug Dipivalyl epinephrine ( Dipivefrin ) Lipophilic increase in corneal absorption Esterase within cornea and aqueous humor 3. Continuous delivery system based upon the osmotic property Thin flat layer, contoured three-dimensional unit Conform to the space of the upper cul-de-sac Delivery of diethyl carbamazine in ocular onchocerciasis4.Gel delivery system: 4.Gel delivery system Biodegradable polyisobutyl-cyano acrylate (PIBCA) colloidal particulate system of pilocarpine to incorporate it into a Pluronic F127 (PF 127)-based gel delivery system. 5)Mucoadhesive Polymer. mucoadhesive polymer, the tamarind seed polysaccharide, as a delivery system for the ocular administration of hydrophilic and hydrophobic antibiotics.Reference:: Reference: N.K.Jain, Advances in Controlled & Novel Drug Delivery, CBS Publication, & distributor, New Delhi, pg No.219-223. Remington & Gennaro ; The Science & Practice Of Pharmacy. Mack Publication Company. Easton, Pennsylvania. Pg. No. 1563-1567. Web Sites: www.vision-care-guide.com www.google/images/eye/anatomy& physiologyThank You....! : Thank You....! Creativity is allowing oneself to make mistakes. Art is knowing which one to keep.